{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:27:06Z","timestamp":1790645226401,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","award":["R42PHAV"],"award-info":[{"award-number":["R42PHAV"]}],"id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004795","name":"Institut Universitaire de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-LABX-0024-PARAFRAP"],"award-info":[{"award-number":["ANR-11-LABX-0024-PARAFRAP"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recent reports documented catastrophic sensitivity failures (18%) of Abbott-Bioline\u2122 Malaria Ag\n                      <jats:italic>Pf\/Pv<\/jats:italic>\n                      rapid diagnostic tests (RDTs) at the Thailand-Myanmar border, prompting WHO to issue an information notice on quality concerns. We evaluated the same RDT lots under controlled laboratory conditions and in a high-transmission field setting in Madagascar to assess whether performance varied across epidemiological contexts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Laboratory evaluation tested four Abbott-Bioline\u2122 Malaria Ag\n                      <jats:italic>Pf\/Pv<\/jats:italic>\n                      lots (05DDI018BH, 05DDI020BA, 05DDI041AB, 05DDI040AA) using serial dilutions of cultured\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      (0\u201360,784 parasites\/\u00b5L). Field evaluation enrolled 218 consecutive febrile patients at Ranomafana health centre, southeastern Madagascar. Performance of both RDTs (Abbott-Bioline\u2122 Malaria Ag\n                      <jats:italic>Pf\/Pv<\/jats:italic>\n                      and Parascreen\u00ae Malaria Ag\n                      <jats:italic>Pf\/Pan<\/jats:italic>\n                      ) was assessed against microscopy and real-time PCR as reference standards.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In laboratory testing, substantial inter-lot variability was observed, with detection failures occurring between 97 and 373 parasites\/\u00b5L. Incomplete blood migration and faint test lines were noted at lower densities. In the field, malaria prevalence was 70.2% by PCR and 48.6% by microscopy. Against microscopy, Abbott-Bioline\u2122 Malaria Ag\n                      <jats:italic>Pf\/Pv<\/jats:italic>\n                      achieved sensitivity of 99.1% (95% CI 94.9\u2013100) and specificity of 93.7% (95% CI 87.4\u201397.4). Parascreen\u00ae Malaria Ag\n                      <jats:italic>Pf\/Pan<\/jats:italic>\n                      showed sensitivity of 100% (95% CI 96.6\u2013100) and specificity of 92.8% (95% CI 86.3\u201396.8). Against PCR, sensitivity decreased to 73.2% for Abbott-Bioline\u2122 Malaria Ag\n                      <jats:italic>Pf\/Pv<\/jats:italic>\n                      and 74.5% for Parascreen\u00ae Malaria Ag\n                      <jats:italic>Pf\/Pan<\/jats:italic>\n                      , while specificity remained 98.5% for both tests. No significant difference was observed between RDTs (p\u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Despite using identical lots that showed 18% sensitivity at the Thailand-Myanmar border, Abbott-Bioline\u2122 Malaria Ag\n                      <jats:italic>Pf\/Pv<\/jats:italic>\n                      RDTs achieved 99.1% sensitivity in Madagascar. This difference likely reflects higher parasite densities in the Malagasy high-transmission setting (geometric mean 10,006 parasites\/\u00b5L) compared to low-transmission elimination contexts. Both RDTs met WHO performance thresholds against microscopy but missed approximately 25% of PCR-positive infections. These findings demonstrate that RDT performance is highly context-dependent and underscore the need for enhanced post-deployment surveillance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-026-05869-1","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:05:51Z","timestamp":1773813951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Field and laboratory evaluation of Abbott-Bioline\u2122 Malaria Ag Pf\/Pv RDT performance in a high-transmission setting: contrasting results with a low-endemic area"],"prefix":"10.1186","volume":"25","author":[{"given":"Jocia","family":"Fenomanana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Ravoavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malalanandrianina","family":"Rakotoarisoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucien","family":"Platon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alioune","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buze","family":"Chala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yssimini Nad\u00e8ge Guill\u00e8ne","family":"Tibiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Caspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emeric","family":"Strubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"Ratsimbasoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"5869_CR1","unstructured":"World Health Organization: World malaria report 2025: addressing the threat of antimalarial drug resistance. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.2025."},{"key":"5869_CR2","unstructured":"World Health Organization: Malaria 2024 Madagascar country profile. Geneva2024."},{"key":"5869_CR3","unstructured":"World Health Organization: Guidelines for the treatment of malaria. Geneva2010."},{"key":"5869_CR4","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria Lancet. 2018;391:1608\u201321.","journal-title":"Malaria Lancet"},{"key":"5869_CR5","doi-asserted-by":"publisher","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"MA Phillips","year":"2017","unstructured":"Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC. Malaria Nat Rev Dis Primers. 2017;3:17050.","journal-title":"Malaria Nat Rev Dis Primers"},{"key":"5869_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12936-025-05577-2","volume":"24","author":"MTT Aung","year":"2025","unstructured":"Aung MTT, Thu AM, Phyo AP, Aung WL, Pateekhum C, Proux S, et al. Investigating the Abbott-Bioline malaria antigen Pf\/Pv rapid diagnostic test. Malar J. 2025;24:343.","journal-title":"Malar J"},{"key":"5869_CR7","doi-asserted-by":"crossref","unstructured":"Thein KS, Soe K, Tun SKS, Kuipers R, Janssen S, Tarning J, Htun Y, Day NP, Kyaw TT, Dondorp AM, et al: The underperforming Abbott-Bioline Malaria Ag P.f\/P.v rapid diagnostic test: a whiter shade of pale - where the truth is not plain to see. Malar J 2025, 24:441.","DOI":"10.1186\/s12936-025-05638-6"},{"key":"5869_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1126\/science.adz3353","volume":"388","author":"C Offord","year":"2025","unstructured":"Offord C. Researchers question Abbott\u2019s rapid malaria tests. Science. 2025;388:898\u20139.","journal-title":"Science"},{"key":"5869_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/536723","volume":"2014","author":"JW Jang","year":"2014","unstructured":"Jang JW, Kim JY, Yoon J, Yoon SY, Cho CH, Han ET, et al. Flow cytometric enumeration of parasitemia in cultures of Plasmodium falciparum stained with SYBR Green I and CD235A. ScientificWorldJournal. 2014;2014:536723.","journal-title":"ScientificWorldJournal"},{"key":"5869_CR10","unstructured":"Bioline\u2122 Malaria Ag P.f\/P.v [https:\/\/www.globalpointofcare.abbott\/ww\/en\/product-details\/bioline-malaria-ag-pf-pv-hrp-2-pldh.html (accessed on February 15, 2026)]"},{"key":"5869_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/1475-2875-12-405","volume":"12","author":"L Canier","year":"2013","unstructured":"Canier L, Khim N, Kim S, Sluydts V, Heng S, Dourng D, et al. An innovative tool for moving malaria PCR detection of parasite reservoir into the field. Malar J. 2013;12:405.","journal-title":"Malar J"},{"key":"5869_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12936-019-3028-z","volume":"18","author":"J Cunningham","year":"2019","unstructured":"Cunningham J, Jones S, Gatton ML, Barnwell JW, Cheng Q, Chiodini PL, et al. A review of the WHO malaria rapid diagnostic test product testing programme (2008\u20132018): performance, procurement and policy. Malar J. 2019;18:387.","journal-title":"Malar J"},{"key":"5869_CR13","doi-asserted-by":"publisher","first-page":"43663","DOI":"10.1038\/s41598-025-97259-x","volume":"15","author":"FD Ojeniyi","year":"2025","unstructured":"Ojeniyi FD, Ayoola AO, Ibitoye O, Opaleye OO, Olowe OA, Ehigie LO, et al. Performance and challenges of malaria rapid diagnostic tests in endemic regions of Africa. Sci Rep. 2025;15:43663.","journal-title":"Sci Rep"},{"key":"5869_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244457","volume":"15","author":"AB Bosco","year":"2020","unstructured":"Bosco AB, Nankabirwa JI, Yeka A, Nsobya S, Gresty K, Anderson K, et al. Limitations of rapid diagnostic tests in malaria surveys in areas with varied transmission intensity in Uganda 2017\u20132019: Implications for selection and use of HRP2 RDTs. PLoS ONE. 2020;15:e0244457.","journal-title":"PLoS ONE"},{"key":"5869_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1590\/S1678-9946201658059","volume":"58","author":"E Tadesse","year":"2016","unstructured":"Tadesse E, Workalemahu B, Shimelis T. Diagnostic performance evaluation of the Sd Bioline malaria antigen Ag Pf\/Pan test (05fk60) in a malaria endemic area of Southern Ethiopia. Rev Inst Med Trop Sao Paulo. 2016;58:59.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"5869_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4269\/ajtmh.24-0197","volume":"111","author":"DC Teou","year":"2024","unstructured":"Teou DC, Dorkenoo AM, Ataba E, Yakpa K, Sossou E, Ma L, et al. Performance of ParaHIT(R) HRP2-based rapid diagnostic test and proportions of Plasmodium falciparum histidine-rich protein 2\/3 gene deletions in Togo. Am J Trop Med Hyg. 2024;111:977\u201383.","journal-title":"Am J Trop Med Hyg"},{"key":"5869_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12936-025-05500-9","volume":"24","author":"DY Some","year":"2025","unstructured":"Some DY, Kiemde F, Sorgho H, Tahita MC, Bere AW, Ouedraogo A, et al. Refining malaria diagnosis in high-transmission areas: a dual-approach with rapid diagnostic tests (RDTs) and dbPCR-NALFIA. Malar J. 2025;24:252.","journal-title":"Malar J"},{"key":"5869_CR18","doi-asserted-by":"publisher","first-page":"1598280","DOI":"10.3389\/fpara.2025.1598280","volume":"4","author":"MA Diallo","year":"2025","unstructured":"Diallo MA, Ndiaye IM, Sow D, Seck MC, Diongue K, Toure M, et al. RDT performance through high-throughput bead-based antigen detection during malaria school survey in Senegal. Front Parasitol. 2025;4:1598280.","journal-title":"Front Parasitol"},{"key":"5869_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.4269\/ajtmh.24-0334","volume":"112","author":"MA Rakotoarisoa","year":"2025","unstructured":"Rakotoarisoa MA, Rakotomanga TA, Fenomanana J, Musango L, Raobela O, Salava J, et al. Performance of the Bioline Malaria Ag Pf\/Pan and Bioline Malaria Ag Pf\/Pv for malaria diagnostics: Madagascar in-country evaluation. Am J Trop Med Hyg. 2025;112:610\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"5869_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12936-018-2371-9","volume":"17","author":"U Dalrymple","year":"2018","unstructured":"Dalrymple U, Arambepola R, Gething PW, Cameron E. How long do rapid diagnostic tests remain positive after anti-malarial treatment? Malar J. 2018;17:228.","journal-title":"Malar J"},{"key":"5869_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00994-24","volume":"12","author":"C Lamsfus Calle","year":"2024","unstructured":"Lamsfus Calle C, Schaumburg F, Rieck T, Nkoma Mouima AM. Martinez de Salazar P, Breil S, Behringer J, Kremsner PG, Mordmuller B, Fendel R: Slow clearance of histidine-rich protein-2 in Gabonese with uncomplicated malaria. Microbiol Spectr. 2024;12:e0099424.","journal-title":"Microbiol Spectr"},{"key":"5869_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12936-022-04387-0","volume":"21","author":"T Oulton","year":"2022","unstructured":"Oulton T, Mahamar A, Sanogo K, Diallo M, Youssouf A, Niambele SM, et al. Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes. Malar J. 2022;21:372.","journal-title":"Malar J"},{"key":"5869_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pt.2019.12.004","volume":"36","author":"KE Poti","year":"2020","unstructured":"Poti KE, Sullivan DJ, Dondorp AM, Woodrow CJ. HRP2: transforming malaria diagnosis, but with caveats. Trends Parasitol. 2020;36:112\u201326.","journal-title":"Trends Parasitol"},{"key":"5869_CR24","doi-asserted-by":"crossref","unstructured":"Tjitra E, Suprianto S, McBroom J, Currie BJ, Anstey NM: Persistent ICT malaria P.f\/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence. J Clin Microbiol 2001, 39:1025\u20131031.","DOI":"10.1128\/JCM.39.3.1025-1031.2001"},{"key":"5869_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12936-016-1529-6","volume":"15","author":"F Grandesso","year":"2016","unstructured":"Grandesso F, Nabasumba C, Nyehangane D, Page AL, Bastard M, De Smet M, et al. Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings. Malar J. 2016;15:496.","journal-title":"Malar J"},{"key":"5869_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12936-022-04103-y","volume":"21","author":"M Mpina","year":"2022","unstructured":"Mpina M, Stabler TC, Schindler T, Raso J, Deal A, Acuche Pupu L, et al. Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea. Malar J. 2022;21:99.","journal-title":"Malar J"},{"key":"5869_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/1475-2875-9-254","volume":"9","author":"I Harris","year":"2010","unstructured":"Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, et al. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J. 2010;9:254.","journal-title":"Malar J"},{"key":"5869_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/eri.13.45","volume":"11","author":"KA Lindblade","year":"2013","unstructured":"Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther. 2013;11:623\u201339.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5869_CR29","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1086\/644781","volume":"200","author":"LC Okell","year":"2009","unstructured":"Okell LC, Ghani AC, Lyons E, Drakeley CJ. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis. 2009;200:1509\u201317.","journal-title":"J Infect Dis"},{"key":"5869_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12936-023-04506-5","volume":"22","author":"S Opoku Afriyie","year":"2023","unstructured":"Opoku Afriyie S, Addison TK, Gebre Y, Mutala AH, Antwi KB, Abbas DA, et al. Accuracy of diagnosis among clinical malaria patients: comparing microscopy, RDT and a highly sensitive quantitative PCR looking at the implications for submicroscopic infections. Malar J. 2023;22:76.","journal-title":"Malar J"},{"key":"5869_CR31","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1038\/nature16039","volume":"528","author":"L Wu","year":"2015","unstructured":"Wu L, van den Hoogen LL, Slater H, Walker PG, Ghani AC, Drakeley CJ, et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. Nature. 2015;528:S86-93.","journal-title":"Nature"},{"key":"5869_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121763","volume":"10","author":"E Lo","year":"2015","unstructured":"Lo E, Zhou G, Oo W, Afrane Y, Githeko A, Yan G. Low parasitemia in submicroscopic infections significantly impacts malaria diagnostic sensitivity in the highlands of Western Kenya. PLoS ONE. 2015;10:e0121763.","journal-title":"PLoS ONE"},{"key":"5869_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263770","volume":"17","author":"Y Yimam","year":"2022","unstructured":"Yimam Y, Mohebali M, Abbaszadeh Afshar MJ. Comparison of diagnostic performance between conventional and ultrasensitive rapid diagnostic tests for diagnosis of malaria: a systematic review and meta-analysis. PLoS ONE. 2022;17:e0263770.","journal-title":"PLoS ONE"},{"key":"5869_CR34","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/j.1469-0691.2011.03639.x","volume":"17","author":"ML McMorrow","year":"2011","unstructured":"McMorrow ML, Aidoo M, Kachur SP. Malaria rapid diagnostic tests in elimination settings\u2013can they find the last parasite? Clin Microbiol Infect. 2011;17:1624\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"5869_CR35","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4269\/ajtmh.18-1013","volume":"100","author":"RK Mehlotra","year":"2019","unstructured":"Mehlotra RK, Howes RE, Cramer EY, Tedrow RE, Rakotomanga TA, Ramboarina S, et al. Plasmodium falciparum Parasitemia and Band Sensitivity of the SD Bioline Malaria Ag Pf\/Pan Rapid Diagnostic Test in Madagascar. Am J Trop Med Hyg. 2019;100:1196\u2013201.","journal-title":"Am J Trop Med Hyg"},{"key":"5869_CR36","unstructured":"Global Malaria Programme [https:\/\/www.who.int\/teams\/global-malaria-programme\/case-management\/diagnosis\/microscopy (accessed on March 9, 2026)]"},{"key":"5869_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03324-3","volume":"19","author":"S Incardona","year":"2020","unstructured":"Incardona S, Bell D, Campillo A, Cunningham J, Ariey F, Fandeur T, et al. Keep the quality high: the benefits of lot testing for the quality control of malaria rapid diagnostic tests. Malar J. 2020;19:247.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05869-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05869-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05869-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:52:49Z","timestamp":1777251169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05869-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5869"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05869-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and received approval from the National Malagasy Ethical Committee (N.44 MSANP\/SG\/AMM\/CERBM, March, 11, 2024). Written informed consent was obtained from all adult participants prior to enrollment. For children, written informed consent was obtained from parents or legal guardians. All participants were informed that participation was voluntary and that refusal would not affect their access to healthcare. All malaria-positive cases received immediate treatment with artesunate-amodiaquine according to Madagascar national treatment guidelines, regardless of study participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}